| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |